日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

P12 接受剂量调整的美法仑-泼尼松-硼替佐米(MPV)治疗的体弱和中等健康新诊断多发性骨髓瘤患者的健康相关生活质量

Proost, Lisa; Lambrecht, Stijn; Hofmans, Mattias; De Vriendt, Ciel; Speeckaert, Marijn; Bonroy, Carolien; Denys, Barbara; De Bruyne, Sander; Maclean, Marsali; Waters, Niamh; Swan, Dawn; Martynchyk, Arina; Smith, Charmaine; Vickers, Darcy; Lee, Denise; Chong, Geoffrey; Hawkes, Eliza A; Bilbao, Cristina; Stuckey, Ruth; Sargas, Claudia; Larráyoz, María J; Chillon, Maria Carmen; Diaz, Rosa Ayala; Carrillo, Estrella Cruz; Yébenes-Ramírez, Manuel; Martinez-Cuadron, David; Rodriguez-Veiga, Rebeca; Gil, Cristina; Bernal, Teresa; Burgues, Juan Miguel Bergua; Algarra, Lorenzo; Tormo, Mar; Sanchez, Maria Pilar Martinez; Saldise, Elena Soria; Serrano, Josefina; Dominguez, Juan Manuel Alonso; Boyero, Raimundo Garcia; Amigo, Maria Luz; Herrera-Puente, Pilar; Sayas, Maria J; Rubira, Esperanza Lavilla; Medina, Carlos Rodriguez; Sosa, Santiago Sánchez; Rodríguez-Afonso, Jorge; Reyes-González-Casanova, Paula; Rodríguez-Arbolí, Eduardo; Garcia, Joaquin Sanchez; Martinez-Lopez, Joaquín; García-Sanz, Ramón; Calasanz, Maria Jose; Barragan, Eva; Casares, Maria Teresa Gomez; Montesinos, Pau; Seefat, MR; Stege, CAM; Timmers, GJ; Levin, MD; Hoogendoorn, M; Ypma, PF; Nijhof, IS; Velders, GA; Strobbe, L; Durdu-Rayman, N; Westerman, M; Davidis-van Schoonhoven, MA; van Kampen, RJW; Beeker, A; Koster, A; Dijk, AC; van de Donk, NWCJ; van der Spek, E; Leys, MBL; Silbermann, MH; Groen, K; van der Burg-de Graauw, NCHP; Sinnige, HAM; van der Hem, KG; Levenga, TH; Bilgin, YM; Sonneveld, P; Klein, SK; Nasserinejad, K; Blommestein, HM; Cucchi, DGJ; Lissenberg-Witte, BI; Zweegman, S

P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL

P05:达拉妥尤单抗联合来那度胺和地塞米松与单用来那度胺和地塞米松治疗既往接受过治疗的多发性骨髓瘤患者:3期POLLUX试验的总生存期结果

Sevindik, Omur Gokmen; Mutlu, Yasa Gul; Aydin, Berrin Balik; Serin, Istemi; Mateos, M; Hari, P; Bahlis, N; Chari, A; van de Donk, NWCJ; Dholaria, B; Garfall, AL; Goldschmidt, H; Kortüm, KM; Krishnan, A; Martin, T; Morillo, D; Oriol, A; Reece, D; Rodriguez, C; Rodríguez-Otero, P; San-Miguel, JF; Usmani, SZ; Verona, R; Lin, SXW; Prior, TJ; Wade, M; Weiss, B; Goldberg, JD; Askari, E; van de Donk, N W C J; Popat, R; Hulin, C; Jagannath, S; Oriol, A; Richardson, P G; Facon, T; Weisel, K; Larsen, J T; Minnema, M; Abdallah, A; Badros, A Z; Knop, S; Stadtmauer, E A; Chen, M; Nguyen, T V; Amin, A; Peluso, T; Lonial, S; Dimopoulos, MA; Oriol, A; Nahi, H; San-Miguel, J; Bahlis, NJ; Usmani, SZ; Rabin, N; Orlowski, RZ; Suzuki, K; Plesner, T; Yoon, SS; Ben Yehuda, D; Richardson, PG; Goldschmidt, H; Reece, D; Ahmadi, T; Qin, X; Garvin Mayo, W; Gai, X; Carey, J; Carson, R; Moreau, P

Carfilzomib for relapsed and refractory multiple myeloma

卡非佐米用于治疗复发和难治性多发性骨髓瘤

Groen, K; van de Donk, Nwcj; Stege, Cam; Zweegman, S; Nijhof, I S